Join us for Harnessing the Potential of Antibody Drug Conjugates (ADCs) in Oncology, on October 25 at Johnson & Johnson Innovation – JLABS @ Washington, DC. We’ll host oncology thoughts leaders from across the industry, Johnson & Johnson Innovation, and Janssen R&D as they dig deeper on how ADCs have become a promising cancer treatment and key component in the next generation of oncology therapeutics.
We will also celebrate the future promise of today’s oncology innovations with a live award announcement for the Advancing Oncology InnoVAtion QuickFire Challenge, hosted in collaboration with Carilion Clinic Innovation, Verge Alliance (with support from City of Roanoke), and Virginia Tech Corporate Research Center (VTCRC). After the programming concludes, there will be an opportunity to participate in partnering meetings to connect one-on-one with industry leaders.